NPM1 and acute myeloid leukemia: Additionally, our results revealed that the cutoff of CLB ≥ 15% identifies NPM1 mutations with a high specificity and positive predictive value (100% and 100%, respectively), with the majority of patients belonging to the AML without- and with-mutation subgroups.